785957003: Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing methyltransferase inhibitor (product)\Catechol-O-methyltransferase inhibitor-containing product\Product containing entacapone (medicinal product)\Product containing entacapone in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing methyltransferase inhibitor (product)\Catechol-O-methyltransferase inhibitor-containing product\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing methyltransferase inhibitor (product)\Catechol-O-methyltransferase inhibitor-containing product\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing levodopa (medicinal product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing entacapone (medicinal product)\Product containing entacapone in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing entacapone (medicinal product)\Product containing entacapone in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing only carbidopa and entacapone and levodopa (medicinal product)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure (product)\Phenolics (substance)\Product containing entacapone (medicinal product)\Carbidopa+levodopa+entacapone\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)

\Product manufactured as oral dose form (product)\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Product containing entacapone in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3769833013 Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3769834019 Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3769833013 Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3769834019 Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Entacapone (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	200	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	trois	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit (attribute)	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Conventional release oral tablet (dose form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Entacapone (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	31.25	false	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	125	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Levodopa (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Levodopa (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Carbidopa anhydrous (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	Antiparkinson therapeutic role	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3769833013	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3769834019	Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3769833013	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3769834019	Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core